# Effect of Consumption of Pep19 on Quality of Life

> **NCT06359327** · NA · COMPLETED · sponsor: **Proteimax Biotechnology Israel LTD** · enrollment: 24 (actual)

## Conditions studied

- Quality of Life
- Obesity
- Sleep Quality

## Interventions

- **DIETARY_SUPPLEMENT:** Placebo
- **DIETARY_SUPPLEMENT:** Pep19 2 mg
- **DIETARY_SUPPLEMENT:** Pep19 5 mg

## Key facts

- **NCT ID:** NCT06359327
- **Lead sponsor:** Proteimax Biotechnology Israel LTD
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-28
- **Primary completion:** 2024-07-28
- **Final completion:** 2024-08-15
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06359327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06359327, "Effect of Consumption of Pep19 on Quality of Life". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06359327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*